# Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia

> **NCT01818310** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital Ostrava** · enrollment: 80 (actual)

## Conditions studied

- Critical Lower Limb Ischemia
- Type-2 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Group A: Intramuscular
- **BIOLOGICAL:** Group B: Intraarterial
- **BIOLOGICAL:** Group C: Intravenous
- **PROCEDURE:** Group D: Surgical endovascular treatment with maximum medicamentous treatment

## Key facts

- **NCT ID:** NCT01818310
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2018-09
- **Final completion:** 2018-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818310, "Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01818310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*